Holly A Hammond

Title: Innovations of Holly A Hammond

Introduction

Holly A Hammond is a notable inventor based in Telford, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of PCSK9 antagonists. With a total of eight patents to her name, her work has the potential to impact the treatment of various health conditions.

Latest Patents

Holly's latest patents include two significant inventions related to PCSK9 antagonists. The first patent, 1B20 PCSK9 antagonists, discloses antagonists of human proprotein convertase subtilisin-kexin type 9 (PCSK9). These antagonists are effective in inhibiting PCSK9 function, making them desirable for treating conditions associated with PCSK9 activity. The invention also includes nucleic acid encoding for these antagonists, vectors, host cells, and compositions comprising the antagonists. Additionally, methods for making PCSK9-specific antagonists and their use in inhibiting or antagonizing PCSK9 function are disclosed. The second patent, 1D05 PCSK9 antagonists, shares similar innovations and applications, further emphasizing the importance of her work in this area.

Career Highlights

Holly has worked with prominent organizations such as Merck Sharp & Dohme Corporation and The Wellcome Trust Limited as Trustee for the Wellcome Trust. Her experience in these esteemed companies has contributed to her expertise in the field of biotechnology and patent development.

Collaborations

Some of her notable coworkers include Jon H Condra and Shilpa Pandit. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Holly A Hammond's contributions to the field of biotechnology, particularly through her patents on PCSK9 antagonists, showcase her innovative spirit and dedication to advancing medical treatments. Her work continues to pave the way for future developments in this critical area of health science.